Skip to main content

Table 2 Subjects who fulfilled at least one of three conditions: a urinary β2-microglobulin (β2MG) level higher than 1000 μg/g cr., blood cadmium higher than 6 μg/L, or urinary cadmium level higher than 10 μg/g cr., out of 35 subjects in Akita Rosai Hospital in Odate city. The values of serum creatinine and urinary α1-microglobulin (α1MG) levels were also presented to support these data. They are listed in order of descending levels of urinary β2MG

From: Hospital-based screening to detect patients with cadmium nephropathy in cadmium-polluted areas in Japan

No.

Sex

Age

Serum creatinine (mg/dL)

Urinary α1MG (mg/g cr.)

Urinary ß2MG (μg/g cr.)

Blood cadmium (μg/L)

Urinary cadmium (μg/g cr.)

Medical history of diagnosed patients

1

F

70

1.70

63.3

34,000

4.8

5.39

 

2a

F

95

0.99

64.2

24,700

6.2

11.9

Hypertension, diabetes

3a

M

81

2.82

62.6

14,700

3.4

10.4

Diabetes

4

F

88

1.14

23.3

13,000

4.7

2.83

 

5a

F

81

2.05

94.3

12,600

11

5.93

Unremarkable

6

F

84

1.22

40.1

7830

7.2

7.21

 

7

F

73

1.10

29.3

7580

4.9

12.0

8

F

74

1.24

35.7

6470

3.4

4.32

9

F

60

1.02

47.3

5800

3.8

9.21

10

F

86

0.88

21.0

3300

4.8

6.38

11

M

79

1.07

11.9

3180

2.1

0.47

12

F

81

0.80

15.9

2630

7.1

8.23

13

M

87

1.60

11.9

2170

2.6

1.90

14

M

80

0.86

17.1

1510

6.0

ND

15

F

91

0.81

7.1

329

7.2

11.0

16

M

78

1.01

8.1

249

7.6

8.46

  1. F female, M male, ND not detected (less than 1.28 ng/mL as an original cadmium level)
  2. aDiagnosed with cadmium nephropathy